Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed route for chroman amides using nitroarenes. Reduces cost and complexity in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN108033866B details a green Ru-catalyzed cyclization for naphthalene derivatives, offering cost reduction in optoelectronic material manufacturing and high-purity pharmaceutical intermediates.
Patent CN107641068A reveals a palladium-catalyzed route for indanone derivatives offering significant supply chain stability and reduced environmental waste for manufacturers.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.
Patent CN113354573A reveals a scalable route for alpha,alpha-terpyridine. Eliminate palladium residues and achieve 99.4% purity for optical and pharma applications.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation route for quinolinone derivatives offering high yields and simplified purification for pharmaceutical intermediates.
Novel cyclization route for spiro-piperidine intermediates offering high yield and scalability for pharmaceutical manufacturing.
Patent CN113735777B reveals a metal-free route for cyclic thiourea compounds. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN115353511A details a safe, multicomponent synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering cost-effective pharmaceutical intermediate manufacturing.
Novel iron-catalyzed C-H/N-H activation route for pyrrolo[1,2-a]indole derivatives. Offers mild conditions, high yields, and cost-effective scalability for API manufacturing.
Patent CN115353511A details a safe, multi-component Pd-catalyzed carbonylation route for indolinone-imidazole derivatives, offering significant supply chain advantages.
Novel elemental sulfur-promoted synthesis avoids peroxides and heavy metals. Cost-effective, scalable route for high-purity pharmaceutical intermediates ensuring supply chain reliability.
Novel nickel-catalyzed method reduces costs and improves safety for 2-pyrrolidone derivatives manufacturing ensuring reliable supply chain continuity.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN111705329B details a green electrochemical route for 5-arylthiouracil. Eliminates oxidants, uses electrons, offers high yield and easy purification for pharma intermediates.
Patent CN112778352B details a novel Pd-catalyzed ortho-C-H silylation method. This route offers high atom economy and streamlined supply chains for pharmaceutical intermediates.
Patent CN115260080B reveals a one-step palladium-catalyzed carbonylation route. This method offers significant supply chain stability and cost optimization for pharmaceutical intermediates.
Patent CN116239623B reveals low-catalyst borate ester synthesis enabling high-purity pharmaceutical intermediate manufacturing with significant supply chain cost optimization.